The pharma companies were asked to keep a close watch on the global supply chain scenario. They were also asked to closely monitor the production and availability of APIs as well as formulations of essential medicines for COVID management. They were asked to ensure adequate stocks and availability of all drugs including COVID drugs in the supply chain up to the retail level.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/qxLFyKr
No comments:
Post a Comment